These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24790523)

  • 1. DDIT3 Expression in Liposarcoma Development.
    Kåbjörn Gustafsson C; Engström K; Aman P
    Sarcoma; 2014; 2014():954671. PubMed ID: 24790523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The myxoid/round cell liposarcoma fusion oncogene FUS-DDIT3 and the normal DDIT3 induce a liposarcoma phenotype in transfected human fibrosarcoma cells.
    Engström K; Willén H; Kåbjörn-Gustafsson C; Andersson C; Olsson M; Göransson M; Järnum S; Olofsson A; Warnhammar E; Aman P
    Am J Pathol; 2006 May; 168(5):1642-53. PubMed ID: 16651630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear expression of FLT1 and its ligand PGF in FUS-DDIT3 carrying myxoid liposarcomas suggests the existence of an intracrine signaling loop.
    Andersson MK; Göransson M; Olofsson A; Andersson C; Aman P
    BMC Cancer; 2010 Jun; 10():249. PubMed ID: 20515481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipomatous tumors.
    Weiss SW
    Monogr Pathol; 1996; 38():207-39. PubMed ID: 8744279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DDIT3 Immunohistochemistry Is a Useful Tool for the Diagnosis of Myxoid Liposarcoma.
    Scapa JV; Cloutier JM; Raghavan SS; Peters-Schulze G; Varma S; Charville GW
    Am J Surg Pathol; 2021 Feb; 45(2):230-239. PubMed ID: 32815829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extensive lipoma-like changes of myxoid liposarcoma: morphologic, immunohistochemical, and molecular cytogenetic analyses.
    Iwasaki H; Ishiguro M; Nishio J; Aoki M; Yokoyama R; Yokoyama K; Taguchi K; Nabeshima K
    Virchows Arch; 2015 Apr; 466(4):453-64. PubMed ID: 25650275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic utility of p16, CDK4, and MDM2 as an immunohistochemical panel in distinguishing well-differentiated and dedifferentiated liposarcomas from other adipocytic tumors.
    Thway K; Flora R; Shah C; Olmos D; Fisher C
    Am J Surg Pathol; 2012 Mar; 36(3):462-9. PubMed ID: 22301498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposarcoma With Hibernoma-like Histology: A Clinicopathologic Study of 16 Cases.
    Kojima N; Komiyama M; Shinoda Y; Watanabe SI; Yatabe Y; Kawai A; Yoshida A
    Am J Surg Pathol; 2022 Oct; 46(10):1319-1328. PubMed ID: 35475774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposarcomas of the mediastinum.
    Suster DI; Suster S
    Mediastinum; 2020; 4():27. PubMed ID: 35118295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The myxoid liposarcoma FUS-DDIT3 fusion oncoprotein deregulates NF-kappaB target genes by interaction with NFKBIZ.
    Göransson M; Andersson MK; Forni C; Ståhlberg A; Andersson C; Olofsson A; Mantovani R; Aman P
    Oncogene; 2009 Jan; 28(2):270-8. PubMed ID: 18850010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amplification of DNA damage-inducible transcript 3 (DDIT3) is associated with myxoid liposarcoma-like morphology and homologous lipoblastic differentiation in dedifferentiated liposarcoma.
    Mantilla JG; Ricciotti RW; Chen EY; Liu YJ; Hoch BL
    Mod Pathol; 2019 Apr; 32(4):585-592. PubMed ID: 30420727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic Value of MDM2 and DDIT3 Fluorescence In Situ Hybridization in Liposarcoma Classification: A Single-Institution Experience.
    Cho J; Lee SE; Choi YL
    Korean J Pathol; 2012 Apr; 46(2):115-22. PubMed ID: 23109990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myxoid liposarcoma with nuclear pleomorphism: a clinicopathological and molecular study.
    Kojima N; Kubo T; Mori T; Satomi K; Matsushita Y; Iwata S; Yatabe Y; Ichimura K; Kawai A; Ichikawa H; Yoshida A
    Virchows Arch; 2024 Jan; 484(1):71-81. PubMed ID: 37704823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell senescence in myxoid/round cell liposarcoma.
    Kåbjörn Gustafsson C; Ståhlberg A; Engtröm K; Danielsson A; Turesson I; Aman P
    Sarcoma; 2014; 2014():208786. PubMed ID: 25093008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of C/EBPα in dedifferentiated liposarcoma induces G2/M cell cycle arrest and apoptosis.
    Wu YV; Okada T; DeCarolis P; Socci N; O'Connor R; Geha RC; Joy Somberg C; Antonescu C; Singer S
    Genes Chromosomes Cancer; 2012 Apr; 51(4):313-27. PubMed ID: 22170698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fusion protein-driven IGF-IR/PI3K/AKT signals deregulate Hippo pathway promoting oncogenic cooperation of YAP1 and FUS-DDIT3 in myxoid liposarcoma.
    Berthold R; Isfort I; Erkut C; Heinst L; Grünewald I; Wardelmann E; Kindler T; Åman P; Grünewald TGP; Cidre-Aranaz F; Trautmann M; Fröhling S; Scholl C; Hartmann W
    Oncogenesis; 2022 Apr; 11(1):20. PubMed ID: 35459264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DDIT3 gene break-apart as a molecular marker for diagnosis of myxoid liposarcoma--assay validation and clinical experience.
    Narendra S; Valente A; Tull J; Zhang S
    Diagn Mol Pathol; 2011 Dec; 20(4):218-24. PubMed ID: 22089349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal and functional TP53 in genetically stable myxoid/round cell liposarcoma.
    Ståhlberg A; Kåbjörn Gustafsson C; Engtröm K; Thomsen C; Dolatabadi S; Jonasson E; Li CY; Ruff D; Chen SM; Åman P
    PLoS One; 2014; 9(11):e113110. PubMed ID: 25393000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposarcomas in young patients: a study of 82 cases occurring in patients younger than 22 years of age.
    Alaggio R; Coffin CM; Weiss SW; Bridge JA; Issakov J; Oliveira AM; Folpe AL
    Am J Surg Pathol; 2009 May; 33(5):645-58. PubMed ID: 19194281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SRC inhibition represents a potential therapeutic strategy in liposarcoma.
    Sievers E; Trautmann M; Kindler D; Huss S; Gruenewald I; Dirksen U; Renner M; Mechtersheimer G; Pedeutour F; Åman P; Nishio J; Schildhaus HU; Kirfel J; Schirmacher P; Wardelmann E; Buettner R; Hartmann W
    Int J Cancer; 2015 Dec; 137(11):2578-88. PubMed ID: 26084847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.